Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...

Shares of Cencora Inc. COR shed 1.64% to $254.21 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index SPX falling 0.50% to 6,040.53 and ...

In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer recently talked about. Jim Cramer, the host of Mad Money, has been ...

We recently compiled a list of the Jim Cramer Shed Light on These 9 Stocks. In this article, we are going to take a look at where Cencora, Inc. (NYSE:COR) stands against the other stocks Jim Cramer ...

Cramer praised Cencora, Inc. (NYSE:COR) but noted that there is a possibility that the stock might go lower. “Cencora, Conshohocken… Used to be the old ABC, AmerisourceBergen. I have to tell ...

Cencora, Inc. COR is well-poised for growth on the back of robust U.S. Healthcare Solutions business and product launches. However, intense competition is a concern. Shares of this Zacks Rank #2 ...

Cencora COR has outperformed the market over the past 10 years by 6.19% on an annualized basis producing an average annual return of 17.58%. Currently, Cencora has a market capitalization of $49. ...

Begin your TipRanks Premium journey today. Cencora (COR) Company Description: Cencora, Inc. engages provision of pharmaceutical products and business solutions that improve access to care.

Shares of Cencora (COR) have been strong performers ... One industry peer that looks good is Medpace Holdings, Inc. (MEDP). MEDP has a Zacks Rank of # 2 (Buy) and a Value Score of C, a Growth ...